Search

everythinglearnresearchcommunity

for

Search:↓

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Raman spectroscopy can help identify cancerous skin tissue during surgery.

JAK1 inhibitors can help reduce itchiness in atopic dermatitis.

The Kras mutation changes normal cell signals, leading to disrupted tissue structure and potential cancer.

Ribonucleotide excision repair is crucial to prevent skin cancer.

A rare genetic deletion in the KRT1 gene causes unique skin symptoms in a family.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Rice bran extract caused moderate skin irritation but no eye irritation, while a diluted essence was not irritating to skin and only slightly to guinea pigs.

Russelia equisetiformis extract protects against liver damage from paracetamol.

Nested PCR can reliably identify fungal infections when traditional methods fail.

A 3-year-old boy had a rare hairball condition usually seen in teenage girls.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Inconsistent safety reporting in chronic back pain trials risks patient safety and decision-making.

LEKTI is crucial for skin barrier and immune function, affecting conditions like Netherton syndrome and atopic dermatitis.

Leporacarus gibbus mite was found in a domestic rabbit in Espírito Santo, Brazil, for the first time.

A new staining method shows a special area in the hair's skin layer with lots of proteoglycans.

Activating autophagy helps skin regenerate better during tissue expansion.

Inactivating both p53 and Rb genes in mice speeds up aggressive skin cancer development.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

JAK inhibitors may help improve symptoms in adults with APECED.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

The oncoprotein causes abnormal hair growth without increasing skin cancer risk.